Skip to content Skip to navigation

Antacids Linked to Better Head and Neck Cancer Survival

Silvana Papagerakis, MD, MS, PhD

Ann Arbor, MI — December 5, 2014 — An adjunct clinical assistant professor at the University of Michigan School of Dentistry has published a research report that shows patients taking antacid medicines to control acid reflux also have better head and neck cancer survival rates.

The study, led by Dr. Silvana Papagerakis, examined nearly 600 patients.  Head and neck cancer specialists often prescribe two types of antacids — proton pump inhibitors or histamine 2 blockers — to patients experiencing acid reflux from chemotherapy or radiation treatments.  Read more…